Besides, NOD2 significantly increased the apoptosis rate of HCC cells after treatment with sorafenib (Fig. 5c), lenvatinib (Fig. 5f) and 5-FU (Fig. 5i). The gene discussed is NOD2; the disease is hepatocellular carcinoma.